$VTVT
vTv Therapeutics Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$32.71
▲+8.94%+$2.68
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatevTv Therapeutics Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is VTVT up today? It is at $32.71 (+8.94%), and our scanner flagged it 7 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VTVT spikes, and full due diligence on VTVT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $VTVT 7 times in the last 30 days. Create a free account to track $VTVT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on VTVT from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Akkaraju Srinivas Director | Acquired (grant/award) | +106K 2.7% of company | added 51% | 313K | $1.6M at $15.27 | Sep 22, 25 |
Baker Bros. Advisors Lp Director | Acquired (grant/award) | +51K 1.3% of company | added 52% | 148K | n/a | Sep 3, 25 |
Sekhri Paul J Officer | Acquired (grant/award) | +2K 0.05% of company | added 58% | 5K | $31K at $16.96 | Nov 18, 24 |
Sekhri Paul J Officer | Acquired (grant/award) | +3K 0.08% of company | n/a | 3K | $52K at $16.35 | Nov 15, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on VTVT from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
VTVT last traded at $32.71, up 8.94% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
vTv Therapeutics Inc. Class A Common Stock (VTVT) is next expected to report earnings on Thursday, November 5, 2026, about 29 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The VTVT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VTVT 7 times in the last 30 days.
VTVT (vTv Therapeutics Inc. Class A Common Stock) trades on XNAS, with a market cap of about $123M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VTVT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$VTVT discussion
Sign in to ask a question or join the discussion.